Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yashma Patel

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annals of Indian Academy of Neurology|February 26, 2010
Pediatric multiple sclerosisYashma Patel, Vikram Bhise, Lauren Krupp
Neuroimage|November 9, 2011
Multiple white matter tract abnormalities underlie cognitive impairment in RRMSHui Jing Yu, Christopher Christodoulou, Vikram Bhise, et al.
Blood|December 8, 2009
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPAAlan K Burnett, Robert K Hills, Claire Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapyDavid Grimwade, Jelena V Jovanovic, Robert K Hills, et al.
The New England Journal of Medicine|January 21, 2016
Assessment of Minimal Residual Disease in Standard-Risk AMLAdam Ivey, Robert K Hills, Michael A Simpson, et al.
Molecular Therapy. Advances|May 15, 2026
A comparison of two manufacturing methods in the phase I COBALT study of CD19CAR T for LBCLClaire Roddie, Juliana Dias, Gordon Weng-Kit Cheung, et al.
Blood|July 11, 2025
Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletionClaire Roddie, Juliana Dias, Maeve O'Reilly, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annals of Indian Academy of Neurology|February 26, 2010
Pediatric multiple sclerosisYashma Patel, Vikram Bhise, Lauren Krupp
Neuroimage|November 9, 2011
Multiple white matter tract abnormalities underlie cognitive impairment in RRMSHui Jing Yu, Christopher Christodoulou, Vikram Bhise, et al.
Blood|December 8, 2009
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPAAlan K Burnett, Robert K Hills, Claire Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapyDavid Grimwade, Jelena V Jovanovic, Robert K Hills, et al.
The New England Journal of Medicine|January 21, 2016
Assessment of Minimal Residual Disease in Standard-Risk AMLAdam Ivey, Robert K Hills, Michael A Simpson, et al.
Molecular Therapy. Advances|May 15, 2026
A comparison of two manufacturing methods in the phase I COBALT study of CD19CAR T for LBCLClaire Roddie, Juliana Dias, Gordon Weng-Kit Cheung, et al.
Blood|July 11, 2025
Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletionClaire Roddie, Juliana Dias, Maeve O'Reilly, et al.
Pageof 1